Seroquel
AstraZeneca jettisons schizophrenia drug for $538 million
May 8, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Luye Pharma, Seroquel, pharma, schizophrenia
AstraZeneca has confirmed it has signed a deal to jettison its schizophrenia drug Seroquel and its extended release version Seroquel …
Seroquel loss hits AstraZeneca
August 2, 2013Sales and Marketing AstraZeneca, Q2, Seroquel, symbicourt
Loss of exclusivity on brands such as the antipsychotic Seroquel IR helped put a $500 million dent in AstraZeneca’s performance …
AstraZeneca sees big sales drop in Q2
July 26, 2012Sales and Marketing AstraZeneca, Brennan, Brilinta, Q2, Seroquel
AstraZeneca has today reported a large drop in revenue for the second quarter. The firm has been hit by major …
Teva launches generic Seroquel in UK
March 27, 2012Sales and Marketing AZ, NHS, Quetiapine, Seroquel, Teva
Teva has launched a generic version of the antipsychotic Seroquel on the same day AstraZeneca loses patent protection on its …
High Court rules against Seroquel XR patent
March 23, 2012Sales and Marketing Accord, AstraZeneca, Sandoz, Seroquel, Teva
A British High Court has ruled that AstraZeneca’s patent on its new formulation of the antipsychotic Seroquel is invalid. Seroquel …
AstraZeneca sues FDA over generic Seroquel
March 14, 2012Manufacturing and Production, Sales and Marketing AstraZeneca, FDA, Seroquel, US, generics
AstraZeneca has said it filed a lawsuit against the US FDA in a bid to block approval of generic versions …
Reckitt painkiller packs may contain antipsychotics, says MHRA
August 26, 2011Manufacturing and Production, Sales and Marketing MHRA, Nurofen, Seroquel, parallel imports
Consumers in the UK are being warned to double-check packs of Reckitt Benckiser’s painkiller product Nurofen Plus following reports that …
AZ adds new heart warning to Seroquel
July 21, 2011Sales and Marketing Seroquel, antipsychotic
AstraZeneca has added a new heart warning to the packaging on its antipsychotic drug Seroquel at the behest of the …
Patent expiries bite into AstraZeneca revenues
October 29, 2010Sales and Marketing AstraZeneca, Crestor, Q3, Seroquel
Generic competition and a major drop off in pandemic influenza products saw AstraZeneca’s revenue fall for the third quarter. Revenue …
AZ’s Seroquel extends European licence
September 3, 2010Sales and Marketing AstraZeneca, Seroquel
AstraZeneca’s controversial anti-psychotic drug Seroquel has been given the green light in Europe as an add-on treatment for serious depressive …
AstraZeneca reaches $200m Seroquel settlement
August 10, 2010Sales and Marketing AstraZeneca, Seroquel
AstraZeneca is to pay around £198 million to settle US lawsuits against its troubled anti-psychotic drug Seroquel. The company has …
AstraZeneca settles Seroquel marketing charges
April 28, 2010Sales and Marketing Seroquel
AstraZeneca has agreed to pay $520 million to settle US federal investigations into the marketing of its antipsychotic blockbuster Seroquel. …
AstraZeneca dodges another Seroquel lawsuit
April 8, 2010Sales and Marketing AZ, Seroquel, US
AstraZeneca has defeated another US lawsuit seeking compensation for diabetes side-effects allegedly caused by its drug Seroquel. A US Federal …
BBC highlights AZ’s Seroquel woes
January 27, 2010Sales and Marketing AstraZeneca, Seroquel, industry reputation
AstraZeneca’s ongoing US legal battle over its antipsychotic drug Seroquel was highlighted this week in a BBC radio programme. AstraZeneca …
Digital Pharma – Byte-sized roundup
January 22, 2010Medical Communications Fresenius Kabi, P&G, Prilosec OTC, Seroquel, Twitter, digital pharma
In this week’s roundup: P&G taps social media for Prilosec OTC, UK launches new data site, analysis of pharma on …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
